FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for treating glial tumors. Method involves injection of a preparation based on manganese (II) hydroxide consisting of globules having a bimodal size distribution in water solution with maxima in range of 7–9 nm and 26–32 nm. Preparation is prepared by hydrolysis of soluble salts Mn (II) at solution pH 8.0–8.6.
EFFECT: use of the invention enables suppressing the growth of a glial tumor.
3 cl, 3 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-TUMOUR AGENT BASED ON RECOMBINANT VACCINIA VIRUS STRAIN AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2730657C1 |
| AGENT HAVING ANTI-TUMOUR ACTIVITY | 2023 |
|
RU2819039C1 |
| 1,1'-(HEXANE-1,6-DIYL)BIS(3-(((1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTAREN-1-YL)METHYL)UREA, WHICH EXHIBITS INHIBITING ACTION ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME AND INCREASES TEMOZOLOMIDE ACTIVITY ON GLIOBLASTOMA CELLS | 2019 |
|
RU2724882C1 |
| 1-ADAMANTYL-3-(((1R,4AS,10AR)-7-ISOPROPYL-1,4A-DIMETHYL-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTHREN-1-YL)METHYL)UREA, WHICH EXHIBITS INHIBITING ACTION ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME AND INCREASES ACTIVITY OF TEMOZOLOMIDE AGAINST GLIOBLASTOMA CELLS | 2019 |
|
RU2697409C1 |
| (17S)-N-BENZYL-5-((3Β-ACETOXY-28-NOR-URS-12-ENE)-17-YL)-1,3,4-OXADIAZOL-2-AMINE, HAVING SELECTIVE CELL CYTOTOXICITY BREAST CANCER MCF-7 | 2019 |
|
RU2708400C1 |
| METHOD FOR PRODUCING NANOSTRUCTURED DOUBLE HYDROXIDES BASED ON ALUMINIUM AND ALKALINE EARTH METALS SUCH AS MAGNESIUM OR CALCIUM, EXHIBITING THE PROPERTY OF INCREASING THE pH OF A CELLULAR MEDIUM, AND NANOSTRUCTURES PRODUCED THEREBY | 2020 |
|
RU2758671C1 |
| RECOMBINANT PLASMID pET-15b_T3_RL DNA PROVIDING SYNTHESIS OF RECOMBINANT FUSION PROTEIN CONSISTING OF TUMOR-SPECIFIC PEPTIDES AND ANTITUMOR PEPTIDE RL2, AND RECOMBINANT FUSION PROTEIN POSSESSING ANTI-TUMOR ACTIVITY AGAINST HUMAN BREAST CANCER | 2016 |
|
RU2619053C1 |
| MEANS FOR HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME INHIBITION | 2015 |
|
RU2612875C1 |
| ANTI-TUMOUR AGENT | 2013 |
|
RU2541130C1 |
| HUMAN BREAST CANCER CELL LINE BrCCh4e | 2019 |
|
RU2717654C1 |
